The side effects that we've already talked about is another problem
81 Unlike long-acting formulations, there is a general consensus that EX-BID is used as an add-on therapy to oral anti-diabetic medications or insulin, which is why its efficacy is usually compared to insulin glargine
Among 21,822 people of European ancestry, we required participants to have complete data needed to construct the target phenotype and GWAS covariates (that is, data available for pre-treatment weight, post-treatment weight, drug type, dosage, time on treatment and factors such as age, sex and height), resulting in 18,488 participants
There is also the routine factor
Age, skin thickness, and previous reaction history all factor into what occurs after an injection